Ryan Specialty Group Stock Performance
| RYAN Stock | USD 68.51 0.30 0.44% |
The company holds a Beta of 0.6, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Ryan Specialty's returns are expected to increase less than the market. However, during the bear market, the loss of holding Ryan Specialty is expected to be smaller as well. At this point, Ryan Specialty Group has a negative expected return of -0.0658%. Please make sure to check Ryan Specialty's value at risk, and the relationship between the jensen alpha and skewness , to decide if Ryan Specialty Group performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Ryan Specialty Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Ryan Specialty is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors. ...more
Actual Historical Performance (%)
One Day Return (0.44) | Five Day Return 2.47 | Year To Date Return 9.39 | Ten Year Return 149.13 | All Time Return 149.13 |
Forward Dividend Yield 0.0064 | Payout Ratio | Forward Dividend Rate 0.44 | Dividend Date 2024-11-26 | Ex Dividend Date 2024-11-12 |
| Ryan Specialty dividend paid on 26th of November 2024 | 11/26/2024 |
1 | Ryan Specialty, LLC Launches Private Offering of 500 Million of Senior Secured Notes | 12/02/2024 |
2 | Disposition of 15000 shares by Mark Katz of Ryan Specialty at 67.3222 subject to Rule 16b-3 | 12/13/2024 |
3 | Disposition of tradable shares by Nicholas Cortezi of Ryan Specialty at 65.0 subject to Rule 16b-3 | 12/20/2024 |
4 | Disposition of 5068 shares by Nicholas Cortezi of Ryan Specialty at 65.1455 subject to Rule 16b-3 | 01/03/2025 |
5 | Disposition of 4900 shares by Nicholas Cortezi of Ryan Specialty at 66.2564 subject to Rule 16b-3 | 01/15/2025 |
6 | Manulife Investment Management Welcomes Ryan Hanna as Global Chief Operating Officer, Private Markets | 01/16/2025 |
7 | Disposition of 4900 shares by Nicholas Cortezi of Ryan Specialty at 67.0052 subject to Rule 16b-3 | 01/17/2025 |
8 | Disposition of 4900 shares by Nicholas Cortezi of Ryan Specialty at 66.9306 subject to Rule 16b-3 | 01/21/2025 |
9 | Disposition of 4900 shares by Nicholas Cortezi of Ryan Specialty at 65.8361 subject to Rule 16b-3 | 01/22/2025 |
10 | Disposition of 4900 shares by Nicholas Cortezi of Ryan Specialty at 65.1273 subject to Rule 16b-3 | 01/23/2025 |
11 | Disposition of 4900 shares by Nicholas Cortezi of Ryan Specialty at 65.0228 subject to Rule 16b-3 | 01/27/2025 |
12 | Disposition of 4900 shares by Nicholas Cortezi of Ryan Specialty at 65.0328 subject to Rule 16b-3 | 01/28/2025 |
13 | Disposition of 8549 shares by Nicholas Cortezi of Ryan Specialty at 66.3285 subject to Rule 16b-3 | 01/30/2025 |
14 | Ryan Specialty Completes Acquisition of Velocity Risk Underwriters | 02/03/2025 |
15 | Willis Towers Watson Q4 Earnings Beat Estimates | 02/04/2025 |
| Begin Period Cash Flow | 1.8 B |
Ryan |
Ryan Specialty Relative Risk vs. Return Landscape
If you would invest 7,169 in Ryan Specialty Group on November 9, 2024 and sell it today you would lose (318.00) from holding Ryan Specialty Group or give up 4.44% of portfolio value over 90 days. Ryan Specialty Group is currently does not generate positive expected returns and assumes 1.4978% risk (volatility on return distribution) over the 90 days horizon. In different words, 13% of stocks are less volatile than Ryan, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Ryan Specialty Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ryan Specialty's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Ryan Specialty Group, and traders can use it to determine the average amount a Ryan Specialty's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0439
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | RYAN |
Estimated Market Risk
| 1.5 actual daily | 13 87% of assets are more volatile |
Expected Return
| -0.07 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Ryan Specialty is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ryan Specialty by adding Ryan Specialty to a well-diversified portfolio.
Ryan Specialty Fundamentals Growth
Ryan Stock prices reflect investors' perceptions of the future prospects and financial health of Ryan Specialty, and Ryan Specialty fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Ryan Stock performance.
| Return On Equity | 0.24 | ||||
| Return On Asset | 0.0399 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.18 % | ||||
| Current Valuation | 11.19 B | ||||
| Shares Outstanding | 125.17 M | ||||
| Price To Earning | 82.48 X | ||||
| Price To Book | 13.55 X | ||||
| Price To Sales | 7.72 X | ||||
| Revenue | 2.08 B | ||||
| Gross Profit | 874.37 M | ||||
| EBITDA | 497.6 M | ||||
| Net Income | 61.04 M | ||||
| Cash And Equivalents | 866.67 M | ||||
| Cash Per Share | 7.76 X | ||||
| Total Debt | 2.16 B | ||||
| Debt To Equity | 3.03 % | ||||
| Current Ratio | 1.18 X | ||||
| Book Value Per Share | 5.06 X | ||||
| Cash Flow From Operations | 477.2 M | ||||
| Earnings Per Share | 0.77 X | ||||
| Market Capitalization | 17.94 B | ||||
| Total Asset | 7.25 B | ||||
| Retained Earnings | 114.42 M | ||||
About Ryan Specialty Performance
By examining Ryan Specialty's fundamental ratios, stakeholders can obtain critical insights into Ryan Specialty's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Ryan Specialty is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | (11.59) | (12.17) | |
| Return On Tangible Assets | 0.01 | 0.01 | |
| Return On Capital Employed | 0.09 | 0.10 | |
| Return On Assets | 0.01 | 0.01 | |
| Return On Equity | 0.10 | 0.12 |
Things to note about Ryan Specialty Group performance evaluation
Checking the ongoing alerts about Ryan Specialty for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Ryan Specialty Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Ryan Specialty Group generated a negative expected return over the last 90 days | |
| Over 88.0% of the company shares are owned by institutional investors | |
| Latest headline from zacks.com: Willis Towers Watson Q4 Earnings Beat Estimates |
- Analyzing Ryan Specialty's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Ryan Specialty's stock is overvalued or undervalued compared to its peers.
- Examining Ryan Specialty's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Ryan Specialty's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Ryan Specialty's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Ryan Specialty's stock. These opinions can provide insight into Ryan Specialty's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ryan Specialty Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Insurance Brokers space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ryan Specialty. If investors know Ryan will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ryan Specialty listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.408 | Dividend Share 0.33 | Earnings Share 0.77 | Revenue Per Share | Quarterly Revenue Growth 0.207 |
The market value of Ryan Specialty Group is measured differently than its book value, which is the value of Ryan that is recorded on the company's balance sheet. Investors also form their own opinion of Ryan Specialty's value that differs from its market value or its book value, called intrinsic value, which is Ryan Specialty's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ryan Specialty's market value can be influenced by many factors that don't directly affect Ryan Specialty's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ryan Specialty's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ryan Specialty is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ryan Specialty's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.